Meropenem-vaborbactam (Vabomere), a new combination antibiotic + inhibitor, now available
www.pulmccm.org
Intensivists have another antibiotic combination to treat severe infections caused by gram-negative bacteria with the FDA’s approval of Vabomere (meropenem, combined with the beta-lactamase inhibitor called vaborbactam). FDA approved Vabomere only for the treatment of complicated urinary tract infections (such as pyelonephritis). However, licensed U.S. physicians routinely prescribe FDA-approved antibiotics “off-label” for other indications.
Meropenem-vaborbactam (Vabomere), a new combination antibiotic + inhibitor, now available
Meropenem-vaborbactam (Vabomere), a new…
Meropenem-vaborbactam (Vabomere), a new combination antibiotic + inhibitor, now available
Intensivists have another antibiotic combination to treat severe infections caused by gram-negative bacteria with the FDA’s approval of Vabomere (meropenem, combined with the beta-lactamase inhibitor called vaborbactam). FDA approved Vabomere only for the treatment of complicated urinary tract infections (such as pyelonephritis). However, licensed U.S. physicians routinely prescribe FDA-approved antibiotics “off-label” for other indications.